Composition of Certain Financial Statement Captions Composition of Certain Financial Statement Captions (Details 3) (USD $) In Thousands, unless otherwise specified	12 Months Ended								12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2013 Sci Gen [Member]	Dec. 31, 2013 Cytochroma [Member]	Dec. 31, 2013 PROLOR [Member]	Aug. 29, 2013 PROLOR [Member]	Dec. 31, 2013 Pharmaceutical [Member] MEXICO	Dec. 31, 2012 Pharmaceutical [Member] MEXICO	Dec. 31, 2013 Pharmaceutical [Member] CHILE	Dec. 31, 2012 Pharmaceutical [Member] CHILE	Dec. 31, 2013 Pharmaceutical [Member] CURNA [Member]	Dec. 31, 2012 Pharmaceutical [Member] CURNA [Member]	Dec. 31, 2013 Pharmaceutical [Member] Farmadiet [Member]	Dec. 31, 2012 Pharmaceutical [Member] Farmadiet [Member]	Dec. 31, 2013 Pharmaceutical [Member] FineTech [Member]	Dec. 31, 2012 Pharmaceutical [Member] FineTech [Member]	Dec. 31, 2013 Pharmaceutical [Member] Sci Gen [Member]	Dec. 31, 2012 Pharmaceutical [Member] Sci Gen [Member]	Dec. 31, 2013 Pharmaceutical [Member] Cytochroma [Member]	Dec. 31, 2012 Pharmaceutical [Member] Cytochroma [Member]	Dec. 31, 2013 Pharmaceutical [Member] PROLOR [Member]	Dec. 31, 2012 Pharmaceutical [Member] PROLOR [Member]	Dec. 31, 2013 Diagnostics [Member] Claros [Member]	Dec. 31, 2012 Diagnostics [Member] Claros [Member]	Dec. 31, 2013 Diagnostics [Member] Opko Diagnostics [Member]	Dec. 31, 2012 Diagnostics [Member] Opko Diagnostics [Member]
Goodwill [Roll Forward]
Beginning balance	$ 80,450	[1]	$ 39,815		$ 760	$ 2,411	$ 139,784	$ 139,784	$ 114	$ 106	$ 6,697	$ 5,282	$ 4,827	$ 4,827	$ 8,712	$ 0	$ 11,698	$ 11,623	$ 796	$ 0	$ 0	$ 0	$ 0	$ 0	$ 17,977	$ 17,977	$ 29,629	$ 0
Acquisitions	142,195		38,739						0	0	0	0	0	0	0	8,313	0	0	0	796	2,411	0	139,784	0	0	0	0	29,629
Foreign exchange, other	3,729		1,896						0	8	(594)	1,415	0	0	363	399	0	74	943	0	(342)	0	0	0	0	0	3,359	0
Ending balance	$ 226,373	[1]	$ 80,450	[1]	$ 760	$ 2,411	$ 139,784	$ 139,784	$ 113	$ 114	$ 6,102	$ 6,697	$ 4,827	$ 4,827	$ 9,075	$ 8,712	$ 11,698	$ 11,698	$ 1,740	$ 796	$ 2,069	$ 0	$ 139,784	$ 0	$ 17,977	$ 17,977	$ 32,988	$ 29,629

[1] As of December 31, 2013 and 2012, total assets include $6.7 million and $5.6 million, respectively, and total liabilities include $10.4 million and $5.5 million, respectively related to SciVac Ltd (“SciVac”), previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and the holders of SciVac’s consolidated liabilities have no recourse against us. Refer to Note 3.